A. Thompson

发表

Comparison of biochars derived from wood pellets and pelletized wheat straw as replacements for peat in potting substrates.

S. C. Peterson, S. Vaughn, J. Kenar, 2013 .

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis.

M. Margaglione, S. Cessie, S. le Cessie, 2012, Blood.

MAPPING OF 6 MONOCLONAL ANTIBODIES TO HUMAN FACTOR IX

S. W. Lin, Shu-Wha Lin, R. Ljung, 1987, Thrombosis and Haemostasis.

Three point mutations in the factor IX genes of five hemophilia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteins.

A. Thompson, S. Chen, M. Zhang, 1989, The Journal of clinical investigation.

Factor IX Chongqing: a New Mutation in the Calcium-Binding Domain of Factor IX Resulting in Severe Hemophilia B

A. Thompson, S. Chen, M. Zhang, 1990, Thrombosis and Haemostasis.

Non-Inversion Factor VIII Mutations in 80 Hemophilia A Families Including 24 with Alloimmune Responses

A. Thompson, Miao‐Liang Liu, S. Nakaya, 2002, Thrombosis and Haemostasis.

Splice junction mutations in factor IX gene resulting in severe hemophilia B.

A. Thompson, G. Bray, S. Chen, 1991, Nucleic acids research.

Isolation and characterization of bovine factor IX (Christmas factor).

K. Fujikawa, E. Davie, A. Thompson, 1973, Biochemistry.

Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate‐P®): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy

J. Gill, A. Thompson, B. Ewenstein, 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical correlates among 49 families with hemophilia A and factor VIII gene inversions

A. Thompson, A. Weinmann, J. Schoof, 1996, American journal of hematology.

Oxygen-17 and aluminium-27 nuclear magnetic resonance spectroscopic investigations of aluminium(III) hydrolysis products

H. S. Gutowsky, E. Oldfield, A. Thompson, 1987 .

HLA‐DR‐restricted T‐cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P

E. James, W. Kwok, A. Thompson, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Loss of tolerance to exogenous and endogenous factor VIII in a mild hemophilia A patient with an Arg593 to Cys mutation.

A. Thompson, J. Healey, P. Lollar, 1997, Blood.

transfer of human factor VIII into hemophilia A mice Immunomodulation of transgene responses following naked DNA

H. Ochs, D. Rawlings, C. Miao, 2013 .

Immunomodulation of transgene responses following naked DNA transfer of human factor VIII into hemophilia A mice.

H. Ochs, D. Rawlings, C. Miao, 2005, Blood.

Characterization of factor IX defects in hemophilia B patients.

A. Thompson, S. Chen, 1993, Methods in enzymology.

Factor IX concentrates for clinical use.

A. Thompson, 1993, Seminars in thrombosis and hemostasis.

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

A. Gown, M. Kay, G. Patijn, 1997, Nature Genetics.

Nonrandom Transduction of Recombinant Adeno-Associated Virus Vectors in Mouse Hepatocytes In Vivo: Cell Cycling Does Not Influence Hepatocyte Transduction

Theresa A. Storm, M. Kay, H. Nakai, 2000, Journal of Virology.

Oestrogen sulfotransferase: molecular cloning and sequencing of cDNA for the bovine placental enzyme.

A. Thompson, E. Thompson, J. Kerr, 1988, Australian journal of biological sciences.

Manual of Hemostasis and Thrombosis

L. Harker, A. Thompson, 1983 .

High-molecular-weight kininogen and the risk of a myocardial infarction and ischemic stroke in young women: the RATIO case-control study

R. Kaufman, M. Morris, A. Thompson, 2012 .

When all else fails to stop massive bleeding from trauma

A. Thompson, 2005, Journal of thrombosis and haemostasis : JTH.

HLA, complement C2, C4, properdin factor B and glyoxalase types in South Indian diabetics.

V. Mohan, Ambady Ramachandran, C. Snehalatha, 1985, Diabetes research and clinical practice.

Cleavage and activation of human factor IX by serine proteases.

A. Thompson, D. Enfield, 1984, Blood.

Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate‐P®)

J. Gill, A. Thompson, B. Ewenstein, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Elevated hemostatic factor levels as potential risk factors for thrombosis.

J. Sprouse, G. Rodgers, A. Thompson, 2002, Archives of pathology & laboratory medicine.

The colonization of the Pacific: the story according to human leukocyte antigens.

A. Thompson, S. Serjeantson, D. P. Ryan, 1982, American journal of human genetics.

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

M. Kay, D. Bellinger, T. Nichols, 1999, Nature Medicine.

CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice.

S. Ziegler, H. Ochs, T. Torgerson, 2009, Blood.

Lineages of human T-cell clones, including T helper 17/T helper 1 cells, isolated at different stages of anti-factor VIII immune responses.

E. James, W. Kwok, A. Thompson, 2009, Blood.

Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients.

A. Bitonti, J. Dumont, L. Valentino, 2012, Blood.

Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro.

M. Kay, G. Patijn, C. Miao, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: a Seattle series

A. Thompson, E. Lovrien, C. Scott, 1991, Human Genetics.

and VIII Deficiency Families ERGIC-53 Gene Structure and Mutation Analysis in 19 Combined Factors V

R. Kaufman, C. Négrier, H. Saito, 2013 .

ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families.

R. Kaufman, C. Négrier, D. Ginsburg, 1999, Blood.

Concentrated von Willebrand factor for treating patients with von Willebrand disease

A. Thompson, 2009 .

High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors.

C. Miao, A. Thompson, X. Ye, 2003, Human gene therapy.

Factor XKetchikan: a variant molecule in which Gly replaces a Gla residue at position 14 in the light chain

A. Thompson, H. James, Deog Joong Kim, 1995, Human Genetics.

Screening for nonsense mutations in patients with severe hemophilia A can provide rapid, direct carrier detection

A. Reiner, A. Thompson, 1992, Human Genetics.

The factor IX BamHI polymorphism: T-to-G transversion at the nucleotide sequence-561

A. Thompson, C. Scott, Shi-han Chen, 1989, Human Genetics.

In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs.

M. Kay, C. Landen, D. Bellinger, 1993, Science.

Concepts of Thrombogenesis and Its Prevention ombosis: Its Role Prevention in diovascular )nts Part

L. Harker, A. Thompson, J. Harlan, 2005 .

Structure and Function of the Factor VIII Gene and Protein

A. Thompson, 2003, Seminars in thrombosis and hemostasis.

Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis

C. Kessler, R. Montgomery, J. Gill, 1996, British journal of haematology.

A family with combined mutations of the hemophilia A and X-linked adrenoleukodystrophy genes

S. Perlman, B. Fogel, A. Thompson, 2008, neurogenetics.

Status of Gene Transfer for Hemophilia A and B

A. Thompson, 1991, Thrombosis and Haemostasis.

Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B.

T. Palmer, A. Miller, A. Thompson, 1989, Blood.

prevalent factor IX dimorphism Carrier testing in hemophilia B with an immunoassay that distinguishes a

Kenneth J. Smith, S. Thibodeau, W. Kisiel, 2011 .

Mapping of monoclonal antibodies to human factor IX

Shu-Wha Lin, J. Ware, A. Thompson, 1989 .

Carrier testing in hemophilia B with an immunoassay that distinguishes a prevalent factor IX dimorphism.

S. Thibodeau, S. W. Lin, W. Kisiel, 1987, Blood.

Oxygen-I 7 and Aluminium-27 Nuclear Magnetic Resonance Spectroscopic Investigations of Aluminium ( 1 1 1 ) Hydrolysis Products

H. S. Gutowsky, E. Oldfield, A. Thompson, 2003 .

Amino acid sequences in lysozyme.

A. Thompson, 1954, Biochimica et biophysica acta.

Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B.

G. Darlington, S. Woo, A. Thompson, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Isolation of a heme protein antigen from Ascaris suum.

A. Thompson, 1972, Biochimica et biophysica acta.

Danazol fails to increase factor VIII or IX levels in a double‐blind crossover study of patients with haemophilia A and B

A. Thompson, G. Bray, D. Nugent, 1986, British journal of haematology.

Use of a BamHI polymorphism in the factor IX gene for the determination of hemophilia B carrier status.

A. Thompson, S. Yong, R. Macgillivray, 1986, Blood.

Ethical issues in haemophilia

A. Chuansumrit, J. Kimmelman, A. Thompson, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

X-linked syndrome of platelet dysfunction, thrombocytopenia, and imbalanced globin chain synthesis with hemolysis.

G. Stamatoyannopoulos, A. Thompson, W. Wood, 1977, Blood.

Pesticide Residues in Soil Invertebrates

A. Thompson, 1973 .

Inhibitors of factor VIII in black patients with hemophilia.

L. Almasy, S. Cole, Karl Fernstrom, 2009, The New England journal of medicine.

FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity.

E. James, A. Thompson, K. Pratt, 2018, Blood advances.

An intragenic deletion of the factor IX gene in a family with hemophilia B.

K. Kurachi, S. Yoshitake, A. Thompson, 1985, The Journal of clinical investigation.

Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure.

K. Fujikawa, B. Shen, B. Stoddard, 2000, Blood.

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

Alan McClelland, Arthur Thompson, Roland W Herzog, 2003, Blood.

Labeled factor IX kinetics in patients with hemophilia-B.

A. Thompson, K. Smith, 1981, Blood.

Molecular biology of the hemophilias.

A. Thompson, 1991, Progress in hemostasis and thrombosis.

Coagulation factor IX: Successful surgical experience with a purified factor IX concentrate

C. Kessler, A. Thompson, E. Gomperts, 1992, American journal of hematology.

Factor VIII mutation and desmopressin‐responsiveness in 62 patients with mild haemophilia A

B. Konkle, A. Thompson, N. Josephson, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

More on: are randomized clinical trials the only truth? Not always

P. Mannucci, C. Kessler, P. Monahan, 2006, Journal of thrombosis and haemostasis : JTH.

Immune tolerance to Factor VIII: the international registry data.

G. Mariani, A. Thompson, M. Manco‐Johnson, 1995, Advances in experimental medicine and biology.

Von Willebrand's disease: clinical management

A. Thompson, G. Castaman, A. Federici, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

Safety and efficacy of solvent/detergent‐treated antihaemophilic factor with an added 80 °C terminal dry heat treatment in patients with haemophilia A

A. Thompson, M. Bush, C. Abildgaard, 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

Recombinant factor IX for the treatment of hemophilia B. Introduction.

A. Thompson, 1998, Seminars in hematology.

B-Cell and T-Cell Epitopes in Anti-factor VIII Immune Responses

A. Thompson, K. Pratt, 2009, Clinical reviews in allergy & immunology.

T‐cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self‐peptide

E. James, W. Kwok, A. Thompson, 2007, Journal of thrombosis and haemostasis : JTH.

Germ line origins of de novo mutations in hemophilia B families

A. Thompson, Shi-han Chen, 1994, Human Genetics.

Structure, function, and molecular defects of factor IX.

A R Thompson, A. Thompson, 1986, Blood.

Monoclonal antibody to an epitope on the heavy chain of factor IX missing in three hemophilia-B patients.

A. Thompson, 1983, Blood.

Heteroduplex screening for molecular defects in factor IX genes from haemophilia B families

A. Thompson, A. Weinmann, J. Schoof, 1995, British journal of haematology.

Factor IX antigen by a rapid staphylococcal protein A‐membrane binding radioimmunoassay: results in haemophilia B patients and carriers and in fetal samples

L. Suzuki, A. Thompson, A. R. Thompson, 1982, British journal of haematology.

Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo.

K. Loeb, C. Miao, A. Thompson, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice.

H. Ochs, R. Kaufman, D. Rawlings, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire.

P. Paz, E. James, A. Thompson, 2016, Blood.

Diagnostic role of an immunoassay-detected polymorphism of factor IX for potential carriers of hemophilia B.

A. Thompson, K. Smith, S. Chen, 1988, Blood.

Severe hemophilia A due to a 1.3 kb factor VIII gene deletion including exon 24: homologous recombination between 41 bp within an Alu repeat sequence in introns 23 and 24

A. Thompson, M. Manco‐Johnson, S. Nakaya, 2004, Journal of thrombosis and haemostasis : JTH.

Molecular Defects in Hemophilia B

A. Thompson, 1991 .

EGF-Iike Regions XIa NORMAL AND HEMOPHILIC FACTOR IXs

A. Thompson, 2005 .

Three missense mutations in Arg codons of the factor VIII genes of mild to moderately severe hemophilia A patients.

A. Reiner, S. Stray, A. Thompson, 1992, Thrombosis research.

Factor IX mutations: rapid, direct screening methods for 20 new families with hemophilia B.

A. Thompson, S. Chen, A. Weinmann, 1992, Thrombosis research.

ALLOANTIBODIES IN HEMOPHILIA B BINDING TO MULTIPLE FACTOR IX (IX) EPITOPES

A. Thompson, 1987, Thrombosis and Haemostasis.

Partial factor IX protein in a pedigree with hemophilia B due to a partial gene deletion.

A. Thompson, G. Bray, 1986, The Journal of clinical investigation.

Factor IX and prothrombin in amniotic fluid and fetal plasma: constraints on prenatal diagnosis of hemophilia B and evidence of proteolysis.

A. Thompson, 1984, Blood.

Factor IX antigen by radioimmunoassay in heterozygotes for hemophilia B.

A. Thompson, 1977, Thrombosis research.

Six Amino Acid Residues in a 1200 Å2 Interface Mediate Binding of Factor VIII to an IgG4κ Inhibitory Antibody

A. Thompson, K. Pratt, Jasper C. Lin, 2015, PloS one.

Pesticides and the soil fauna.

C. Edwards, A. Thompson, 1973, Residue reviews.

Extrudates of Cornstarch with Urea and Glycols: Structure/Mechanical Property Relations

C. Swanson, A. Thompson, R. Shogren, 1992 .

Solid state aluminum-27 NMR studies of tridecameric Al-OxoHydroxy clusters in basic aluminum selenate, sulfate, and the mineral zunyite

H. S. Gutowsky, E. Oldfield, A. Thompson, 1984 .

Movement of dieldrin through soils. II.-In sloping troughs and soil columns.

C. Edwards, A. Thompson, K. Beynon, 1970 .

A minor globin gene of the bivalve mollusc Anadara trapezia.

N. Nassif, A. Thompson, E. Thompson, 1991, Biochimica et biophysica acta.

Polymer compatibility and biodegradation of Starch-poly(ethylene-co-acrylic acid)-polyethylene blends

S. Gordon, R. Greene, A. Thompson, 1992 .

Human plasma P component: isolation and characterization.

A. Thompson, D. Enfield, 1978, Biochemistry.

Construction and identification by partial nucleotide sequence analysis of bovine casein and beta-lactoglobulin cDNA clones.

A. F. Stewart, A. Caputo, A. Thompson, 1982, DNA.

X-linked syndrome of platelet dysfunction, thrombocytopenia, and imbalanced globin chain synthesis with hemolysis.

G. Stamatoyannopoulos, A. Thompson, W. Wood, 1977, Blood.

The factor VIII C1 domain contributes to platelet binding.

A. Thompson, K. Pratt, Ting-Chang Hsu, 2008, Blood.

In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.

M. Kay, C. Landen, S. Wiehle, 1994, Proceedings of the National Academy of Sciences of the United States of America.

High affinity binding of human and bovine thrombins to p-chlorobenzylamido-ϵ-aminocaproyl agarose

A. Thompson, 1976 .

Factor XII and Other Hemostatic Protein Abnormalities in Nephrotic Syndrome Patients

A. Thompson, A. R. Thompson, 1982, Thrombosis and Haemostasis.

Inhibition of thrombin by sarin.

A. Thompson, 1970, Biochimica et biophysica acta.

Affinity chromatography of thrombin.

E. Davie, A. Thompson, 1971, Biochimica et biophysica acta.

Movement of dieldrin through soils. I. From arable soils into ponds.

C. Edwards, A. Thompson, K. Beynon, 1970 .

IL-17 Is Secreted by T-Cell Clones Isolated Following An Initial Peak Inhibitor Response to Factor VIIII, Suggesting Th17 Cells Play a Role in Inhibitor Development

E. James, W. Kwok, A. Thompson, 2008 .

Treatment type and amount influenced human immunodeficiency virus seroprevalence of patients with congenital bleeding disorders.

A. Thompson, M. J. Clements, G. Gjerset, 1991, Blood.

Characterization of coal macerals using combined chemical and NMR spectroscopic methods

A. Thompson, R. Botto, John V. Muntean, 1989 .

Seashore mallow (Kosteletzkya pentacarpos) stems as a feedstock for biodegradable absorbents

S. Vaughn, B. Moser, B. Dien, 2013 .

Complexes of starch polysaccharides and poly(ethylene co‐acrylic acid): Structural characterization in the solid state

S. Gordon, R. Greene, A. Thompson, 1991 .

Severe haemophilia B due to a 6 kb factor IX gene deletion including exon 4: Non-homologous recombination associated with a shortened transcript from whole blood

A. Thompson, S. Nakaya, Ting-Chang Hsu, 2007, Thrombosis and Haemostasis.

Air Classification of Pin-Milled Soybean Hulls

Y. Wu, A. Thompson, W. Wolf, 2002 .

Persistence of chlorfenvinphos in natural waters

C. Edwards, A. Thompson, K. Beynon, 1971 .

Control of wireworms with organophosphorus and carbamate insecticides

C. Edwards, A. Thompson, 1971 .

Preparation of a weakly basic ion exchanger by crosslinking starch with epichlorohydrin in the presence of NH4OH1

J. A. Laszlo, A. Thompson, I. Šimkovic, 1996 .

Factors XWenatchee I and II: compound heterozygosity involving two variant proteins.

A. Thompson, H. James, D. Nash, 1995, Biochimica et biophysica acta.

The use of CP/MAS 13C-NMR for evaluating starch degradation in injection molded starch-plastic composites

S. Gordon, R. Greene, A. Thompson, 1993 .

A domain mutations in 65 haemophilia A families and molecular modelling of dysfunctional factor VIII proteins

M. Murphy, A. Thompson, Miao‐Liang Liu, 1998, British journal of haematology.

Gene therapies for the hemophilias.

A. Thompson, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

NMR of Layered Silicates in Argonne Coals and Geochemical Implications

A. Thompson, R. Botto, 2001 .

Some factor VIII exon 14 frameshift mutations cause moderately severe haemophilia A

A. Thompson, Miao‐Liang Liu, S. Nakaya, 2001, British journal of haematology.

An HhaI polymorphism is present in factor IX genes of Asian subjects

A. Reiner, A. Thompson, 1990, Human Genetics.

A 50 bp polymorphic insertion in the factor IX gene is readily detected by amplification and is in equilibrium with other polymorphic sites.

A. Thompson, S. Chen, D. P. Bouvier, 1990, Nucleic Acids Research.

Point Mutations in Four Hemophilia B Patients from China

A. Thompson, S. Chen, N. Wang, 1990, Thrombosis and Haemostasis.

Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001–2003

J. Goedert, M. Lederman, J. Goedert, 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

Human thrombin: partial primary structure.

A. Thompson, J. Fenton, M. Legaz, 1977, Archives of biochemistry and biophysics.

Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease

R. Watts, E. Kraut, B. Kerlin, 2009, Haemophilia.

Factor IX Denver, ASN 346→ASP Mutation Resulting in a Dysfunctional Protein with Defective Factor VIIIa Interaction

A. Thompson, M. Manco‐Johnson, R. Nuss, 2001, Thrombosis and Haemostasis.

Isolation and characterisation of a mast cell degranulating substance from Ascaris suum.

A. Thompson, 1972, Biochimica et biophysica acta.

Decreased reactivity of organophosphorus inhibitors towards a modified chymotrypsin.

A. Thompson, R. Ellin, 1970, Biochimica et biophysica acta.

Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients.

A. Bitonti, J. Dumont, L. Valentino, 2012, Blood.

A moderate form of hemophilia B is caused by a novel mutation in the protease domain of factor IXVancouver.

R. MacGillivray, G. Brayer, G. Louie, 1989, The Journal of biological chemistry.